AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
ROSUVASTATIN 10 Mg ; EZETIMIBE 10 Mg ;
9 registrations across 1 African market— 9 active
Markets with ROSUVASTATIN 10 Mg ; EZETIMIBE 10 Mg ;
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Rosuvamib 10/10 mg Film Coated Tablets | 🇪🇬Egypt | El Delta for Pharmaceutical Industries - Delta Pharma | active | — |
| Suvreza® 10mg/ 10mg Film Coated Tablets | 🇪🇬Egypt | SANOFI scientific office | active | — |
| Larosuzet 10/ 10 mg Film Coated Tablets | 🇪🇬Egypt | AL ESRAA PHARMACEUTICAL OPTIMA-EGYPT | active | — |
| Suvreza® 10mg/ 10mg Film Coated Tablets | 🇪🇬Egypt | SANOFI scientific office | active | — |
| Crestolip Plus 10/10 mg Film Coated Tablets | 🇪🇬Egypt | Global Advanced pharmaceuticals "GAP" | active | — |
| Rosuvamib 10/10 mg Film Coated Tablets | 🇪🇬Egypt | El Delta for Pharmaceutical Industries - Delta Pharma | active | — |
| Crestolip Plus 10/10 mg Film Coated Tablets | 🇪🇬Egypt | Global Advanced pharmaceuticals "GAP" | active | — |
| Pentarousve 10/10 mg Film Coated Tablets | 🇪🇬Egypt | penta pharma egypt | active | — |
| Pentarousve 10/10 mg Film Coated Tablets | 🇪🇬Egypt | penta pharma egypt | active | — |
ROSUVASTATIN 10 Mg ; EZETIMIBE 10 Mg ; in Africa — Regulatory Overview
ROSUVASTATIN 10 Mg ; EZETIMIBE 10 Mg ; is registered across 1 African markets with 9 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Egypt. AfricaRegulatory refreshes this data daily from official government sources.
Of the 9 registrations, 9 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.